TIL Ltd is offering an issue size valued at Rs 49.08 Crores. The subscription for this Right Issue will be open from April 26, 2024, to May 10, 2024. For every fully paid-up equity share held on the record date of March 22, 2024, shareholders are entitled to ₹28 Rights equity shares. The face value of each share is Rs. 10, with the Right Issue price set at Rs. 10 per share.
Corporate Action | |
---|---|
Security Name | TIL Ltd |
Issue Open/Close | April 26, 2024 - May 10, 2024 |
Record Date | March 22, 2024 |
Issue Size (Amount) | ₹49.08 Crores |
Issue Size (Shares) | ₹49,075,199 |
Right Issue Price | ₹10 per share |
Face Value | ₹10 Per Shares |
CMP | ₹240 |
Renunciation of Rights Entitlements | May 6, 2024 |
Terms of Payment | The full amount of the Issue Price being 10 will be payable on application |
Entitlement | ₹28 Rights Equity Shares for every 10 fully paid-up Equity Shares held on Record Date |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.